Abstract
Background: The Myelodysplastic Syndromes are a group of clonal disorders of hematopoiesis characterized by inefficient hematopoiesis, peripheral blood cytopenias, dysplasia hematopoietic in one or more cell of the myeloid lineage, and increased risk of progression to acute myeloid leukemia (LMA). The clinical phenotype of patients with MDS are diverse with respect to the number and sever…